| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.54 | 0.05 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |